Background/Aim: The diagnosis of palmoplantar melanoma is often delayed and misdiagnosis is common, due to frequently unusual clinical presentation. We used a digital dermoscopy analyzer with a series of palmoplantar pigmented skin lesions (PP-PSL), and we compared sensitivity, specificity and diagnostic accuracy obtained with digital dermoscopy analysis (DDA) and classical dermoscopy. Methods: Digital dermoscopy images of 107 PP-PSL were retrospectively obtained from the database of images of 3 Italian centers. The lesions (25 melanomas and 82 nevi) were all removed because of the presence of clinical and/or dermoscopic suspicious features. All digital images were analyzed using appropriate algorithms, and the diagnostic accuracy of the model was calculated. For comparison, dermoscopic images were clinically evaluated by two dermatologists and the Cohen ĸ concordance with DDA was calculated. Results: The stepwise logistic regression analysis selected only 5 parameters out of 49. The logistic model achieved a sensitivity of 96% and a specificity of 87.8%. The Cohen ĸ concordance, evaluated by the Landis and Koch scale, supplied a substantial agreement between dermoscopy and DDA. Conclusions: DDA might be a useful diagnostic instrument in the evaluation of preselected PP-PSL. However, these findings should be confirmed in a formal clinical trial.

Keywords:
Acral lentiginous melanoma, Dermoscopy, Digital dermoscopy analysis
1.
Coleman WP 3rd, Loria PR, Reed RJ, Krementz ET: Acral lentiginous melanoma. Arch Dermatol 1980;116:773–776.
2.
Ridgeway CA, Hieken TJ, Ronan SG, Kim DK, Das Gupta TK: Acral lentiginous melanoma. Arch Surg 1995;130:88–92.
3.
Porras BH, Cockerell CJ: Cutaneous malignant melanoma: classification and clinical diagnosis. Semin Cutan Med Surg 1997;16:88–96.
4.
Piliang MP: Acral lentiginous melanoma. Clin Lab Med 2011;31:281–288.
5.
Stalkup JR, Orengo IF, Katta R: Controversies in acral lentiginous melanoma. Dermatol Surg 2002;28:1051–1059.
6.
Chi Z, Li S, Sheng X, Si L, Cui C, Han M, Guo J: Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer 2011;25:85.
7.
Palicka GA, Rhodes AR: Acral melanocytic nevi: prevalence and distribution of gross morphologic features in white and black adults. Arch Dermatol 2010;146:1085–1094.
8.
Hudson DA, Krige JE: Melanoma in black South Africans. J Am Coll Surg 1995;180:65–71.
9.
Kuchelmeister C, Schaumburg-Lever G, Garbe C: Acral cutaneous melanoma in Caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol 2000;143:275–280.
10.
Kogushi-Nishi H, Kawasaki J, Kageshita T, Ishihara T, Ihn H: The prevalence of melanocytic nevi on the soles in the Japanese population. J Am Acad Dermatol 2009;60:767–771.
11.
Durbec F, Martin L, Derancourt C, Grange F: Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol 2012;166:727–739.
12.
Bradford PT, Goldstein AM, McMaster ML, Tucker MA: Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986–2005. Arch Dermatol 2009;145:427–434.
13.
Phan A, Touzet S, Dalle S, Ronger-Savlé S, Balme B, Thomas L: Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 2006;155:561–569.
14.
Soon SL, Solomon AR Jr, Papadopoulos D, Murray DR, McAlpine B, Washington CV: Acral lentiginous melanoma mimicking benign disease: the Emory experience. J Am Acad Dermatol 2003;48:183–188.
15.
Argenziano G, Soyer HP: Dermoscopy of pigmented skin lesions – a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001;2:443–449.
16.
Puig S, Argenziano G, Zalaudek I, Ferrara G, Palou J, Massi D, Hofmann-Wellenhof R, Soyer HP, Malvehy J: Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma. Dermatol Surg 2007;33:1262–1273.
17.
Venugopal SS, Soyer HP, Menzies SW: Results of a nationwide dermoscopy survey investigating the prevalence, advantages and disadvantages of dermoscopy use among Australian dermatologists. Australas J Dermatol 2011;52:14–18.
18.
De Giorgi V, Grazzini M, Rossari S, Gori A, Alfaioli B, Papi F, Savarese I, Cervadoro E, Lotti T: Adding dermatoscopy to naked eye examination of equivocal melanocytic skin lesions: effect on intention to excise by general dermatologists. Clin Exp Dermatol 2011;36:255–259.
19.
Saida T, Oguchi S, Miyazaki A: Dermoscopy for acral pigmented skin lesions. Clin Dermatol 2002;20:279–285.
20.
Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, Yoshikawa S, Tsuchida T, Kawabata Y, Tamaki K: Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol 2004;140:1233–1238.
21.
Zalaudek I, Zanchini R, Petrillo G, Ruocco E, Soyer HP, Argenziano G: Dermoscopy of an acral congenital melanocytic nevus. Pediatr Dermatol 2005;22:188–191.
22.
Bowling J, Argenziano G, Azenha A, Bandic J, Bergman R, Blum A, Cabo H, Di Stephani A, Grichnik J, Halpern A, Hofman-Wellenhof R, Johr R, Kittler H, Kopf A, Kreusch J, Langford D, Malvehy J, Marghoob A, Menzies S, Ozdemir F, Peris K, Piccolo D, Pizzichetta MA, Polsky D, Puig S, Rabinovitz H, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Soyer HP, Tanaka M, Zalaudek I, Braun RP: Dermoscopy key points: recommendations from the international dermoscopy society. Dermatology 2007;214:3–5.
23.
Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, Binder M, Cerroni L, De Rosa G, Ferrara G, Hofmann-Wellenhof R, Landthaler M, Menzies SW, Pehamberger H, Piccolo D, Rabinovitz HS, Schiffner R, Staibano S, Stolz W, Bartenjev I, Blum A, Braun R, Cabo H, Carli P, De Giorgi V, Fleming MG, Grichnik JM, Grin CM, Halpern AC, Johr R, Katz B, Kenet RO, Kittler H, Kreusch J, Malvehy J, Mazzocchetti G, Oliviero M, Ozdemir F, Peris K, Perotti R, Perusquia A, Pizzichetta MA, Puig S, Rao B, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Stanganelli I, Tanaka M, Westerhoff K, Wolf IH, Braun-Falco O, Kerl H, Nishikawa T, Wolff K, Kopf AW: Dermoscopy of pigmented skin lesions: results of a consensus meeting via the internet. J Am Acad Dermatol 2003;48:679–693.
24.
Rubegni P, Burroni M, Cevenini G, Perotti R, Dell’Eva G, Barbini P, Fimiani M, Andreassi L: Digital dermoscopy analysis and artificial neural network for the differentiation of clinically atypical pigmented skin lesions: a retrospective study. J Invest Dermatol 2002;119:471–474.
25.
Elbaum M, Kopf AW, Rabinovitz HS, Langley RG, Kamino H, Mihm MC Jr, Sober AJ, Peck GL, Bogdan A, Gutkowicz-Krusin D, Greenebaum M, Keem S, Oliviero M, Wang S: Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol 2001;44:207–218.
26.
Ercal F, Chawla A, Stoecker WV, Lee HC, Moss RH: Neural network diagnosis of malignant melanoma from color images. IEEE Trans Biomed Eng 1994;41:837–845.
27.
Rubegni P, Cevenini G, Burroni M, Perotti R, Dell’Eva G, Sbano P, Miracco C, Luzi P, Tosi P, Barbini P, Andreassi L: Automated diagnosis of pigmented skin lesions. Int J Cancer 2002;101:576–580.
28.
Seidenari S, Pellacani G, Pepe P: Digital videomicroscopy improves diagnostic accuracy for melanoma. J Am Acad Dermatol 1998;39:175–181.
29.
Ganster H, Pinz A, Roehrer R, Wilding E, Binder M, Kitter H: Automated melanoma recognition. IEEE Trans Med Imaging 2001;20:233–239.
30.
Celebi ME, Kingravi HA, Uddin B, Iyatomi H, Aslandogan YA, Stoecker WV, Moss RH: A methodological approach to the classification of dermoscopy images. Comput Med Imaging Graph 2007;31:362–373.
31.
Hoffmann K, Gambichler T, Rick A, Kreutz M, Anschuetz M, Grünendick T, Orlikov A, Gehlen S, Perotti R, Andreassi L, Newton Bishop J, Césarini JP, Fischer T, Frosch PJ, Lindskov R, Mackie R, Nashan D, Sommer A, Neumann M, Ortonne JP, Bahadoran P, Penas PF, Zoras U, Altmeyer P: Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. Br J Dermatol 2003:149:801–809.
32.
Blum A, Luedtke H, Ellwanger U, Schwabe R, Rassner G, Garbe C: Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. Br J Dermatol 2004;151:1029–1038.
33.
Iyatomi H, Celebi M, Oka H, Tanaka M: An Internet-based melanoma screening system with acral volar lesion support. Conf Proc IEEE Eng Med Biol Soc 2008;51:56–59.
34.
Koga H, Saida T: Revised 3-step dermoscopic algorithm for the management of acral melanocytic lesions. Arch Dermatol 2011;147:741–743.
35.
Dreiseitl S, Ohno-Machado L: Logistic regression and artificial neural network classification models: a methodology review. J Biomed Inform 2002;35:352–359.
36.
Jennrich RI: Stepwise discriminant analysis; in Enslein K, Ralston A, Wilf HS (eds): Statistical Methods for Digital Computers. New York, Wiley, 1977, pp 76–95.
37.
Fukunaga K: Introduction to Statistical Pattern Recognition. Boston, Academic Press, 1990.
38.
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174.
39.
SPSS Advanced Models™, version 10.0.
40.
Cai JJ, Smith DK, Xia X, Yuen KY: MBEToolbox: a MATLAB toolbox for sequence data analysis in molecular biology and evolution. BMC Bioinformatics 2005;6:64.
41.
Phan A, Dalle S, Touzet S, Ronger-Savlé S, Balme B, Thomas L: Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population. Br J Dermatol 2010;162:765–771.
42.
Saida T, Koga H, Uhara H: Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol 2011;38:25–34.
43.
Rubegni P, Burroni M, Nami N, Cevenini G, Bono R, Sbano P, Fimiani M: Objective melanoma progression. Skin Res Technol 2011;17:69–74.
44.
Stoecker WV, Wronkiewiecz M, Chowdhury R, Stanley RJ, Xu J, Bangert A, Shrestha B, Calcara DA, Rabinovitz HS, Oliviero M, Ahmed F, Perry LA, Drugge R: Detection of granularity in dermoscopy images of malignant melanoma using color and texture features. Comput Med Imaging Graph 2011;35:144–147.
45.
Uehara J, Ito Y, Takahashi I, Honma M, Ishida-Yamamoto A, Matsuo S, Iizuka H: Sequential acral lentiginous melanomas of the foot. Case Rep Dermatol 2010;2:201–206.
46.
Zhou Y, Smith M, Smith L, Warr R: A new method describing border irregularity of pigmented lesions. Skin Res Technol 2010;16:66–76.
47.
Lee TK, Claridge E: Predictive power of irregular border shapes for malignant melanomas. Skin Res Technol 2005;11:1–8.
48.
Albreski D, Sloan SB: Melanoma of the feet: misdiagnosed and misunderstood. Clin Dermatol 2009;27:556–563.
49.
Pereyra-Rodríguez JJ, Pulpillo A, Zulueta-Dorado T, Conejo-Mir J: Acral lentiginous melanoma mimicking pyogenic granuloma. Med Clin (Barc) 2010;135:193.
50.
Chamberlain A, Ng J: Cutaneous melanoma – atypical variants and presentations. Aust Fam Physician 2009;38:476–482.
51.
Nagashima Y, Akita M, Tsuchida T: Relationship between the three-dimensional structure of the human plantar epidermis and the dermoscopic patterns seen in melanocytic nevi. Dermatology 2011;222:67–73.
52.
Pellacani G, Longo C, Malvehy J, Puig S, Carrera C, Segura S, Bassoli S, Seidenari S: In vivo confocal microscopic and histopathologic correlations of dermoscopic features in 202 melanocytic lesions. Arch Dermatol 2008;144:1597–1608.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.